| Product NDC: | 62756-634 |
| Proprietary Name: | Risperidone |
| Non Proprietary Name: | Risperidone |
| Active Ingredient(s): | 4 mg/1 & nbsp; Risperidone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62756-634 |
| Labeler Name: | Sun Pharmaceutical Industries Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078464 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130413 |
| Package NDC: | 62756-634-18 |
| Package Description: | 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62756-634-18) |
| NDC Code | 62756-634-18 |
| Proprietary Name | Risperidone |
| Package Description | 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62756-634-18) |
| Product NDC | 62756-634 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Risperidone |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20130413 |
| Marketing Category Name | ANDA |
| Labeler Name | Sun Pharmaceutical Industries Limited |
| Substance Name | RISPERIDONE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |